Audit in the management of gliomas

References

• Rubinstein L J. Tumors of the central nervous system. Atlas of Tumor Pathology, Series 2, Armed Forces Institute of Pathology, Washington, DC 1972; 1, Fascicle 6
   Google Scholar
• Walker M D. Brain and peripheral nervous system tumors. Cancer Medicine, 2nd edn, J F Holland, E Frei, III. Lea & Febiger, Philadelphia 1982; 1603–47
   Google Scholar
• Hegedus K, Molnar P. Primary cerebellar glioblastoma multiforme with an unusually long survival. J Neurosurg 1983; 58: 589–92
   Google Scholar
• Salford L G, Brun A, Nirfalk S. Ten year survival among patients with supratentorial astrocytoma grade III and IV. J Neurosurg 1988; 69: 506–9
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observation. J Am Statistics Assoc 1958; 53: 457–581
   Google Scholar
• Salcman M, Kaplan R S, Samaras G M, Ducker T B, Broadwell R D. Aggressive multimodality therapy based on a multicompartmental mode of glioblastoma. Surgery 1982; 92: 250–9
   Google Scholar
• Burger P C, Dubois P J, Clifford Schold S, et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 1983; 58: 159–69
   PubMed Web of Science ®Google Scholar
• Green B S, Byar D P, Walker M D, Pistenma D A, Alexander E, Jr., Batzdorf U. Comparisons of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67: 121–32
   PubMedGoogle Scholar
• Kistler J P, Hochberg F H, Brooks B R, Richardson E P, Jr., Neu P FJ, Schnur J. Computerized axial tomography: clinicopathological correlation. Neurology 1975; 25: 201–9
   Google Scholar
• Marshall L F, Jennett B, Langfitt T W. Needle biopsy for the diagnosis of malignant glioma. JAMA 1974; 228: 1417–18
   PubMed Web of Science ®Google Scholar
• Scherer H J. The forms of growth in gliomas and their practical significance. Brain 1940; 63: 1–35
   Google Scholar
• Nazzaro J M, Neuwelt E A. The role of surgery in the manaement of supratentorial intermediate and highgrade astrocytoma in adults. J Neurosurg 1990; 73: 331–44
   PubMed Web of Science ®Google Scholar
• Ammirati M, Vick N, Liao Y, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987; 21: 201–6
   PubMed Web of Science ®Google Scholar
• Garfield J. Surgery of malignant gliomas. Brain Tumors: scientific basic, clinical investigations, and current therapy, D GT Thomas, D I Graham. Butterworths, London 1980; 301–21
   Google Scholar
• Berry M P, Jenkin R TD, Keen C W, Nair B D, Simpson W J. Radiation treatment for medulloblastoma: a 21-year-review. J Neurosurg 1981; 55: 43–51
   PubMedGoogle Scholar
• Cooper J S, Borok T L, Ransohoff J, Carella R. Malignant glioma: results of combined modality therapy. JAMA 1982; 248: 62–5
   PubMed Web of Science ®Google Scholar
• Walker M D. Malignant glioma. Current Surgical Management of Neurological Disease, C B Wilson, J T Hoff. Churchill Livingstone, New York 1980; 72–8
   Google Scholar
• Walker R W, Posner J B. Central nervous system neoplasms. Curr Neurol 1984; 5: 285–322
   Google Scholar
• Laws E R, Jr., Taylor W F, Clifton M B, Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984; 61: 665–73
   PubMed Web of Science ®Google Scholar
• Berger M S, Kincaid J, Ojemann G A, Lettich E. Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumors. Neurosurgery 1989; 25: 786–91
   PubMed Web of Science ®Google Scholar
• McBlack P L, Ronner S F. Cortical mapping for defining the limits of tumor resection. Neurosurgery 1987; 20: 914–19
   Google Scholar
• Gregorie E M, Goldring S. Localization of function in the excision of lesions from the sensorimotor region. J Neurosurg 1984; 61: 1047–54
   PubMed Web of Science ®Google Scholar
• Hirakawa K, Suzuki K, Udea S, Nakagawa Y, Ibayashi N, Hayashi K. Multivariate analysis of factors affecting postoperative survival in malignant astrocytoma. J Neuro-Oncol 1984; 2: 331–40
   PubMed Web of Science ®Google Scholar
• Young B, Oldfield E H, Markesbery W R, et al. Reoperation for glioblastoma. J Neurosurg 1981; 55: 917–21
   PubMed Web of Science ®Google Scholar
• Pool J L. The management of recurrent gliomas. Clin Neurosurg 1968; 15: 265–87
   PubMedGoogle Scholar
• Geharn E A, Walker M D. Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 1977; 46: 189–95
   Google Scholar
• Jelsma R, Bucy P C. The treatment of glioblastoma multiforme of the brain. J Neurosurg 1967; 27: 338–400
   Google Scholar
• Jelsma R, Bucy P C. Glioblastoma multiforme. Arch Neurol 1969; 20: 161–71
   Google Scholar
• Salcman M. Survival in glioblastoma: historical perspective. Neurosurgery 1980; 7: 435–9
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Hoshino K. Statistical analysis of factors affecting survival after glioblastoma multiforme. Acta Neurochir (Wein) 1977; 37: 57–73
   PubMed Web of Science ®Google Scholar
• Walker M D, Alexander E, Jr., Hunt W E, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978; 49: 333–43
   PubMed Web of Science ®Google Scholar
• Al-Mefty O, Al-Rodhan N RF, Phillips R L, El-Sennosi M, Fox J L. Factors affecting survival of children with malignant gliomas. Neurosurgery 1987; 20: 416–20
   PubMedGoogle Scholar
• Trojanowski T, Peszynski J, Turowski K, et al. Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 1989; 70: 18–23
   PubMed Web of Science ®Google Scholar
• Leibel S A, Sheline G E. Radiation therapy for neoplasms of the brain. J Neurosurgery 1987; 66: 1–22
   PubMed Web of Science ®Google Scholar
• Kornblith P L, Walker M. Chemotherapy for malignant gliomas. J Neurosurg 1988; 68: 1–17
   PubMed Web of Science ®Google Scholar
• Levin V A, Wara W M, Davis R L, et al. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy and hydroxyurea for malignant glioma. J Neurosurg 1985; 63: 218–23
   PubMed Web of Science ®Google Scholar
• Murovic J, Turowski K, Wilson C B, Hoshino T, Levin V. Computerized tomography in the prognosis of malignant cerebral gliomas. J Neurosurg 1986; 65: 799–806
   Google Scholar